The following represents disclosure information provided by authors of this abstract. ASCO's Quality Care Symposium Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pattern of chemotherapy use at end of life (EOL) in patients with solid tumors (ST).
Thomas W. Burke
No relevant relationships to disclose
Yvette A DeJesus
No relevant relationships to disclose
Lee Cheng
No relevant relationships to disclose
Aman Buzdar
No relevant relationships to disclose
Maria Alma Rodriguez
No relevant relationships to disclose